Chronic Myeloid Leukemia: Long-Term Outcome Data in the Imatinib Era

Recent reports suggest that in the TKI era, the survival of chronic myeloid leukemia approaches that of general population. The real-world situation may be different. We analyzed patients (≥ 18 years) with chronic phase (CP) CML enrolled over a 7-year period (2002–2008) in an imatinib access program...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Indian J Hematol Blood Transfus
Главные авторы: Ganesan, Prasanth, Ganesan, Trivadi S., Radhakrishnan, Venkatraman, Sagar, Tenali Gnana, Kannan, Krishnarathinam, Dhanushkodi, Manikandan, Kalayarasi, Jayachandran Perumal, Mehra, Nikita
Формат: Artigo
Язык:Inglês
Опубликовано: Springer India 2018
Предметы:
Original Article
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC6369098/
https://ncbi.nlm.nih.gov/pubmed/30828146
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s12288-018-1009-y
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы